Home LiteratureArticle Details
PMID: 3474420 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S.

Virus attenuation and identification of structural proteins of vaccinia virus that are selectively modified during virus persistence.

Journal of virology ·Vol. 61 ·No. 8 ·1987-08-00 ·Pages 2642-7

Paez E, Dallo S, Esteban M

Abstract

To investigate the genetic stability of vaccinia virus DNA, we have tested whether alterations occurred in the polypeptide composition of this complex virus during persistent infections. We found that variants isolated at various passages in Friend erythroleukemia cells persistently infected with vaccinia virus contained, in addition to an 8-megadalton (MDa) deletion on the left terminus of the viral genome, major alterations in the sizes of three structural proteins with molecular masses of about 39, 21, and 14 kDa. Alterations in isoelectric points were also observed in proteins of 48, 27, and 14 kDa. The 14-kDa protein is part of the virus envelope, and the variants increased the size of this protein from 0.5 to 3 kDa with increasing passage number. Alteration in size of the 14-kDa protein is a dominant trait since it appeared in the whole virus population by passage 48. With more passages, some variants were found to increase or decrease the size of a 39-kDa core protein by about 2 kDa and to decrease the size of an envelope protein of 21 kDa by about 2 kDa. These three proteins were immunogenic in mice and elicited a strong host immune response. Major alterations in the sizes of these proteins were prevented by continuous treatment of the persistently infected cultures with interferon. However, after interferon was removed, protein modifications appeared with increasing passage number. Generation of the 8-MDa deletion and alterations in the size of the 14-kDa protein correlated with a marked decrease in virulence of these variants. Our findings suggest that during virus persistence, specific mutations are introduced in the vaccinia virus genome that lead to protein alterations and to highly attenuated viruses.

MeSH Terms
Animals Antigens, Viral/analysis Cells, Cultured DNA, Viral/genetics Genes, Viral Isoelectric Point Leukemia, Erythroblastic, Acute/microbiology Mice Molecular Weight Mutation Time Factors Vaccinia/microbiology Vaccinia virus/pathogenicity,physiology Viral Proteins/immunology,physiology
Chemicals
Antigens, Viral DNA, Viral Viral Proteins
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Paez E
Dallo S
Esteban M
References (16)
16 references, click to expand
  1. Biogenesis of poxviruses: interrelationship between hemagglutinin production and polykaryocytosis.
    Virology. 1971 Dec;46(3):533-43 PMID: 4109523
  2. Role of prostaglandins and non-steroid anti-inflammatory drugs in the pathogenicity of vaccinia virus.
    J Gen Virol. 1987 Feb;68 ( Pt 2):593-600 PMID: 3819698
  3. Molecular genetics of herpes simplex virus. II. Mapping of the major viral glycoproteins and of the genetic loci specifying the social behavior of infected cells.
    J Virol. 1979 Feb;29(2):677-97 PMID: 219254
  4. Biogenesis of vaccinia: evidence for more than 100 polypeptides in the virion.
    Virology. 1979 Jun;95(2):385-94 PMID: 462799
  5. Conservation and variation in Orthopoxvirus genome structure.
    J Gen Virol. 1979 Dec;45(3):683-701 PMID: 232137
  6. Interferon inhibits transformation of mouse cells by exogenous cellular or viral genes.
    Nature. 1983 Jun 2-8;303(5916):433-5 PMID: 6190086
  7. Resistance of vaccinia virus to interferon is related to an interference phenomenon between the virus and the interferon system.
    Virology. 1984 Apr 15;134(1):12-28 PMID: 6324465
  8. Analysis of replicating vaccinia DNA in interferon-treated, virus-infected cells.
    J Interferon Res. 1984 Spring;4(2):179-92 PMID: 6747347
  9. Inhibitory effect of interferon on the genetic and oncogenic transformation by viral and cellular genes.
    J Virol. 1985 Apr;54(1):229-32 PMID: 3973979
  10. Generation of a dominant 8-MDa deletion at the left terminus of vaccinia virus DNA.
    Proc Natl Acad Sci U S A. 1985 May;82(10):3365-9 PMID: 2987924
  11. Interferon inhibits marker rescue of vaccinia virus.
    J Interferon Res. 1985 Spring;5(2):247-56 PMID: 4009001
  12. Antiviral and antiproliferative properties of interferons: mechanism of action.
    Prog Med Virol. 1985;32:159-73 PMID: 2410953
  13. Interferon prevents the generation of spontaneous deletions at the left terminus of vaccinia virus DNA.
    J Virol. 1985 Oct;56(1):75-84 PMID: 3861876
  14. Isolation and characterization of neutralizing monoclonal antibodies to vaccinia virus.
    J Virol. 1985 Nov;56(2):482-8 PMID: 4057358
  15. A 14,000-Mr envelope protein of vaccinia virus is involved in cell fusion and forms covalently linked trimers.
    J Virol. 1987 Feb;61(2):395-404 PMID: 3806791
  16. Biogenesis of vaccinia: isolation and characterization of a surface component that elicits antibody suppressing infectivity and cell-cell fusion.
    Virology. 1976 Nov;75(1):232-41 PMID: 982851
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
1987-08-00
Pages
2642-7
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC255716
Subset
IM
Grants
NCI NIH HHS · CA 44262 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]